NCT06323096

Brief Summary

The goal of this observational study is to develop a Clinical Decision Support System for severe patients with polytrauma. The main questions it aims to answer are:

  • Is it possible to predict the development of systemic inflammatory response syndrome for the next 24 h after admission?
  • Is it possible to predict the development of blood loss \>25% of blood volume for the next 24 h after admission?
  • Is it possible to predict the development of acute traumatic coagulopathy for the next 24 h after admission?
  • Is it possible to predict the development of pneumonia in polytrauma patients?
  • Is it possible to predict the outcome in polytrauma patients? No intervention is planned for this study.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2020

Completed
3.3 years until next milestone

First Submitted

Initial submission to the registry

March 14, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 21, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

March 21, 2024

Status Verified

March 1, 2024

Enrollment Period

3.8 years

First QC Date

March 14, 2024

Last Update Submit

March 14, 2024

Conditions

Keywords

severe polytraumaclinical decision support system

Outcome Measures

Primary Outcomes (4)

  • Prediction of SIRS

    Rate of SIRS prediction in the 24 h after admission using the developed CDSS.

    By the end of January 2024

  • Rate of ATC prediction in the 24 h after admission using the developed CDSS.

    Rate of ATC prediction in the 24 h after admission using the developed CDSS.

    By the end of January 2024

  • Rate of hemorrage prediction in the 24 h after admission using the developed CDSS.

    Rate of hemorrage prediction in the 24 h after admission using the developed CDSS.

    By the end of January 2024

  • Rate of pneumonia prediction using the developed CDSS.

    Rate of pneumonia prediction within all period of admission using the developed CDSS.

    By the end of January 2024

Study Arms (4)

Polytrauma with SIRS

No intervention(s) to be administered.

Polytrauma with Bloodloss

No intervention(s) to be administered.

Polytrauma with ATC

No intervention(s) to be administered.

Polytrauma with Pneumonia

No intervention(s) to be administered.

Eligibility Criteria

Age28 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

According to the World Health Organization (WHO forecast, by 2030 trauma is one of the five leading causes of death. In the Republic of Kazakhstan, road traffic injuries rank 7th among all causes of death (14.7 \[the 10-year average is 16.9\] per 100,000 population per year). Considering geographical and epidemiological factors, we chose two regional medical centers and the National Scientific Center of Traumatology and Orthopedics in the Republic of Kazakhstan, providing emergency medical care to patients with polytrauma (the serviced population is 610,000, 1,135,000, and 1,400,000 people, respectively).

You may qualify if:

  • Availability of informed consent, signed by the patient or his legal representative;
  • Patients over 18 years of age;
  • Expanded criteria of the new Berlin definition of polytrauma: patients who comply with three conditions:
  • Presence of damage to one area of the body with an AIS score ≥3 points.
  • Presence of damage to ≥2 areas of the body with an AIS score of ≥2.
  • Presence of ≥1 physiological risk factors and/or primary hospitalization in the ICU.
  • Completeness of the medical record in terms of laboratory and instrumental studies and protocol of therapeutic and surgical treatment.

You may not qualify if:

  • Refusal to participate in the study at any stage.
  • Death within one hour after hospitalization.
  • Missing data.
  • Patients who seek primary care 24 hours after injury.
  • Patients requiring transfer between profiles and hospitals for implementation of rehabilitation or other stages of therapy.
  • Patients with prematurely interrupted treatment.
  • Trauma combined with suffocation, drowning, frostbite, electrical trauma, or chemical and/or thermal burns.
  • Patients with pathological fractures.
  • Pregnant women.
  • Cases with predominantly severe craniocephalic (GCS \<7 points) or spinal injury (deep paresis and plegias).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emergency Hospital

Semey, Abai, 071400, Kazakhstan

RECRUITING

Related Publications (1)

  • Prokazyuk A, Tlemissov A, Zhanaspayev M, Aubakirova S, Mussabekov A. Development and validation of a machine learning-based model to assess probability of systemic inflammatory response syndrome in patients with severe multiple traumas. BMC Med Inform Decis Mak. 2024 Aug 27;24(1):235. doi: 10.1186/s12911-024-02640-x.

MeSH Terms

Conditions

Multiple Trauma

Condition Hierarchy (Ancestors)

Wounds and Injuries

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Anesthesiology and ICU specialist

Study Record Dates

First Submitted

March 14, 2024

First Posted

March 21, 2024

Study Start

December 1, 2020

Primary Completion

September 1, 2024

Study Completion

December 31, 2024

Last Updated

March 21, 2024

Record last verified: 2024-03

Locations